Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

Impact of early-onset colorectal cancer on utilization of chemotherapy and outcomes in patients with stage II disease. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers ...

The study revealed that out of 140,528 pregnancies, 5,879 were initially identified as high-risk through traditional early trimester screenings. However, by integrating NIPT with the pregascreen ...

Unintended Consequences in Cancer Care Delivery Created by the Medicare Part B Proposal: Is the Clinical Rationale for the Experiment Flawed?